Belimumab Clinical Trials

6 actively recruiting trials across 3 locations

▲ +2 trials since June 2026

Also known as: Any other treatment, Benlysta

Pipeline

Phase 1: 2Phase 2: 2Phase 4: 2

Top Sponsors

Sichuan Baili Pharmaceutical Co., Ltd.1
Peking Union Medical College Hospital1
Northwell Health1
Nanjing University School of Medicine1
NYU Langone Health1

Indications

Lupus5
Systemic Lupus Erythematosus2
Arthritis2
Rheumatic Disease1
Lupus Nephritis (LN)1

Other3 trials

A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Systemic Lupus Erythematosus

Phase 1

Belimumab After Rituximab in Resistant Primary Juvenile SS

Phase 4

The Efficacy and Safety of Biologics (Belimumab/ Telitacicept) Induction Therapy in Proliferative Lupus Nephritis Patients for 6 Months Compared With Mycophenolate Mofetil Treatment

Phase 2

Scottsdale, Arizona1 trial

A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants

GSK Investigational Site

Phase 1

Manhasset, New York1 trial

Trial of Belimumab in Early Lupus

Feinstein Institute

Phase 4

New York, New York1 trial

Immunosuppressant Management in Rheumatology Patients Undergoing Elective Total Shoulder Arthroplasty

NYU Langone Health

Phase 2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.